Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

The inaugural ASCO-SITC Clinical Immuno-Oncology Symposium will have three networking sessions, designed to help physicians determine how immunotherapy best fits into their practice, and to explore career development for newcomers to the field of immunotherapy.
When faced with a diagnosis of cancer, my patients and their families show more courage than I could ever have imagined.
A highly interactive and personal panel discussion and Q&A session will take place in the evening on January 26, before the official opening of the Cancer Survivorship Symposium in San Diego, CA.
Do you belong to your ASCO State/Regional Affiliate? If not, you should! Do you take advantage of all they have to offer? If not, you should! You, and more importantly your patients, will benefit enormously.
Dr. Maher Saifo, an oncologist practicing in Syria, discusses how the Syrian war is affecting cancer care in a post written with his patient, Lama Meer Yousef. Together, they share their story of survival and hope against incredible odds.
Attend the 2017 Cancer Survivorship Symposium's Presidents Panel to hear Drs. Wanda Filer, Nitin Damle, and Julie M. Vose discuss how professional societies are workingto meet the needs of their members with respect to the care of cancer survivors.
With new therapies, fortunately, oncologists are now seeing patients over the span of years, and we get to know the person who is the patient beyond their illness. Many also bring along others on visit after visit, and we get to know each of them too.
When I first took the helm of ASCO’s member publication in 2006, ASCO Connection was very different—so different, in fact, that it was not even called ASCO Connection!
The advent of rapid and relatively affordable high-throughput molecular analyses has permitted the development of a bewildering next generation of new cancer diagnostic tests that are being introduced into clinical care using our grandparents’ regulatory structure.
I cannot count the number of times I have thought to myself, “If it were not for the PSA, you would no doubt be out there playing golf, skiing, biking, taking a grandchild to the park, or just enjoying life.” Living from one PSA to the next is a bad way to mark the passing of time.
This new meeting will focus on the clinical application of immunology to cancer care, including immune checkpoint inhibitor therapy and novel combinations, the use of adoptive T-cell therapy and CAR T-cells, predictive and prognostic biomarkers, and more.
ASCO provides answers to some of the most frequently asked questions about the Society's proposed pathway for Maintenance of Certification, in response to your insightful feedback.
As a physician and a mom, I'm doing what all human beings do every day: making decisions about my life, career, and relationships, and hoping for the best.
As we move forward in oncology, my hope is that we will see miraculous recoveries more often, guided not by chance but by a better understanding of cancer biology. The promise of precision medicine remains a real one that I firmly believe in.
Dr. Smita Bhatia reflects on Dr. Anna T. Meadows' achievements and contributions to the field of survivorship as the 2017 Cancer Survivorship Symposium approaches.
As oncologists, we are shaped and molded by our patients. December is a perfect time to reflect on our patients and ourselves, with the hope that we will be able to improve our future.
Survival rates for many types of cancers have continued to improve over the past several decades, contributing to a growing number of long-term cancer survivors. With longer survival, attention to the chronic and long-term adverse treatment effects has become increasingly important.
Writing a prescription is the easiest part of we do in clinic. The harder part is truly understanding the financial burden a cancer diagnosis inflicts on patients and their families.

Pages


Advertisement